Matthew Wagar - Delivra Health VP Innovation

DHBUF Stock  USD 0.01  0.0002  1.67%   

Insider

Matthew Wagar is VP Innovation of Delivra Health Brands
Webhttps://delivrahealthbrands.com

Delivra Health Management Efficiency

The company has return on total asset (ROA) of (0.2226) % which means that it has lost $0.2226 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.0056) %, meaning that it generated substantial loss on money invested by shareholders. Delivra Health's management efficiency ratios could be used to measure how well Delivra Health manages its routine affairs as well as how well it operates its assets and liabilities.
Delivra Health Brands has accumulated 1.67 M in total debt with debt to equity ratio (D/E) of 0.38, which is about average as compared to similar companies. Delivra Health Brands has a current ratio of 1.0, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Delivra Health until it has trouble settling it off, either with new capital or with free cash flow. So, Delivra Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Delivra Health Brands sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Delivra to invest in growth at high rates of return. When we think about Delivra Health's use of debt, we should always consider it together with cash and equity.
Harvest One Cannabis Inc., through its subsidiaries, develops and provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. Harvest One Cannabis Inc. is headquartered in Vancouver, Canada. Delivra Health is traded on OTC Exchange in the United States. Delivra Health Brands [DHBUF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

Delivra Health Brands Leadership Team

Elected by the shareholders, the Delivra Health's board of directors comprises two types of representatives: Delivra Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Delivra. The board's role is to monitor Delivra Health's management team and ensure that shareholders' interests are well served. Delivra Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Delivra Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gord Davey, CEO Pres
Ann Gallery, Sr Communications
CPA CMA, CFO Sec
Matthew Wagar, VP Innovation
Will Stewart, Sr Affairs
CPA CGA, VP Fin
Jonathan Hartshorn, Pres Satipharm
Frank MBA, Independent Chairman

Delivra Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Delivra Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Delivra OTC Stock

Delivra Health financial ratios help investors to determine whether Delivra OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Delivra with respect to the benefits of owning Delivra Health security.